
Syneos Health SYNH
Quartalsbericht 2023-Q2
hinzugefügt 16.05.2026
Syneos Health EV/EBITDA 2011-2026 | SYNH
EV/EBITDA Jährlich Syneos Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.06 | 22.6 | 23.8 | 22.1 | 21.9 | 45.1 | 17.5 | 16.1 | 16.6 | 9.56 | 20.8 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 45.1 | 7.06 | 20.3 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
-227 | $ 19.72 | 2.71 % | $ 572 M | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 16.36 | 2.57 % | $ 495 M | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 114.94 | 1.22 % | $ 9.48 B | ||
|
Agilent Technologies
A
|
27.4 | $ 113.33 | 2.5 % | $ 34.5 B | ||
|
Interpace Biosciences
IDXG
|
3.62 | $ 1.8 | - | $ 7.96 M | ||
|
Celcuity
CELC
|
-32.4 | $ 138.86 | 6.03 % | $ 6.49 B | ||
|
Co-Diagnostics
CODX
|
0.0391 | $ 2.31 | 17.26 % | $ 3.07 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Illumina
ILMN
|
70.5 | $ 141.35 | -0.24 % | $ 22.5 B | ||
|
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
-38.2 | $ 113.24 | 15.33 % | $ 14.2 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 21.1 | 2.78 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
15.5 | $ 96.33 | 3.7 % | $ 6.5 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 421.05 | 0.27 % | $ 12.1 B | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
627 | $ 1 082.63 | 3.03 % | $ 22.3 B | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
14.3 | $ 19.2 | 2.4 % | $ 430 M | ||
|
Natera
NTRA
|
-19.5 | $ 202.96 | 3.53 % | $ 20 B | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 156.38 | 2.59 % | $ 7.75 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Personalis
PSNL
|
-4.87 | $ 7.86 | 11.58 % | $ 701 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.79 | 4.77 % | $ 1.13 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-1.79 | $ 3.74 | 5.21 % | $ 346 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
Koninklijke Philips N.V.
PHG
|
17.1 | $ 26.76 | 2.71 % | $ 25.4 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 449.72 | 0.43 % | $ 170 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 5.69 | 2.62 % | $ 237 M | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 54.25 | 9.6 % | $ 3.24 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
186 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.35 | -1.26 % | $ 5.4 M | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 0.6 | 6.65 % | $ 216 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 257.11 | 1.35 % | $ 21.4 B | ||
|
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
60.2 | $ 341.81 | 2.57 % | $ 20.4 B | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 8.73 | 4.49 % | $ 1.89 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 193.73 | 1.75 % | $ 21.5 B |